Beyond Basic Beta Channel Expect Pharmaceuticals M&A Activity to Rebound After COVID-19 Eases By Tom LydonApril 17, 2020
ETF Strategist Channel A Look at the S&P Sectors from 2019 By Canterbury Investment ManagementJanuary 8, 2020
Relative Value Channel Could Coiled Volatility Suggest A Bigger Stock Move Is Coming? By Ian YoungNovember 11, 2019
Beyond Basic Beta Channel 8 ETFs to Capture Opportunities in Healthcare Sector By Max ChenAugust 22, 2019
Innovative ETFs Channel AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs By Max ChenJune 25, 2019
Beyond Basic Beta Channel 4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat By Ben HernandezApril 9, 2019
Innovative ETFs Channel Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results By Max ChenFebruary 28, 2019
